Alto Neuroscience ANRO
NYSE ANRO
$25.57 -0.99 (-3.73%)
At close: Sep 30, 2026 · 4:00 PM EDT

Alto Neuroscience (ANRO) Other financing activities (2025 - 2026)

Updated

Alto Neuroscience's Other financing activities came in at $190,000 for Q1 2026, up 49.6% from $127,000 a year earlier.

Analysis

Alto Neuroscience (ANRO) Other financing activities (2025 - 2026) Analysis & Trends

For FY2025, Alto Neuroscience's Other financing activities was $127,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Alto Neuroscience 897.35 Mn 897.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 190,000.00
Mar 31, 2025 127,000.00
API Access

Alto Neuroscience Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ANRO&period=max&api_key=YOUR_API_KEY